REGN
Regeneron Pharmaceuticals, Inc.
$631.81
1.09 (0.17%) Today
— up— down
Ex-Dividend Date
May 20, 2026
May 20, 2026Open
$636.54
$636.54Previous Close
$632.90
$632.90Day Range
$626.86 – $638.30
$626.86 – $638.3052-Week Range
$518.90 – $821.11
$518.90 – $821.11Volume
701.13K
701.13KExchange
NasdaqGS
NasdaqGSAbout REGN
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
Related
News
Comcast's NBCUniversal spinoff raises hope for more deals. There may not be good options
CNBC · 1h ago
Wall Street indexes rise as US, Iran attacks ease; major tech-related shares jump - Reuters
Reuters · 1h ago
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
CNBC · 1h ago
Chip stocks rebound, and Goldman racks up a series of M&A wins
CNBC · 1h ago
Here's how Trump Accounts could affect women's retirement savings gap
CNBC · 2h ago